Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A8813 NSC697923Target: Ub-conjugating enzyme (E2) complexSummary: Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective
-
B1492 PYR-412 CitationTarget: ProteasomeSummary: inhibitor of Ubiquitin-Activating Enzyme (E1)
-
B2168 NMS-8733 CitationTarget: Valosin-containing protein (VCP)Summary: VCP/p97 inhibitor,selective and allosteric
-
B1317 ML-323Target: Deubiquitinating enzymes (DUBs)Summary: USP1-UAF1 inhibitor
-
A3023 P0050911 CitationTarget: Ubiquitin-specific proteasesSummary: Ubiquitin-specific protease 7 (USP7) inhibitor
-
A4007 MLN97083 CitationTarget: ProteasomeSummary: Proteasome inhibitor
-
A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent
-
A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor
-
A2583 Lactacystin (Synthetic)1 CitationTarget: ProteasomeSummary: Proteasome inhibitor
-
A2606 Epoxomicin25 CitationSummary: Proteasome inhibitor